Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
7,845 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01242943 | Radioimmunotherapy With 131I-L19SIP in Patients With Cancer | terminated | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 2 | Nov 22, 2011 | clinicaltrials |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 21 | Nov 16, 2011 |
| clinicaltrials |
| NCT00174655 | BIG 02/98 Docetaxel - Breast Cancer | completed | Phase 3 | 2,887 | SanofiINDUSTRY | 21 | Nov 10, 2011 | clinicaltrials |
| NCT00518895 | Trial of Dacarbazine With or Without Genasense in Advanced Melanoma(AGENDA) | completed | Phase 3 | 300 | Genta IncorporatedINDUSTRY | 12 | Nov 7, 2011 | clinicaltrials |
| NCT00519090 | Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)(ENEST) | terminated | Phase 3 | 6 | Novartis PharmaceuticalsINDUSTRY | 10 | Nov 7, 2011 | clinicaltrials |
| NCT01459328 | Resource-Sparing Curative Treatment for Rectal Cancer | unknown | Phase 3 | 350 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 25, 2011 | clinicaltrials |
| NCT00907348 | Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma(REAL07) | unknown | Phase 2 | 49 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01009970 | Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma | unknown | Phase 2 | 50 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01149174 | Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer(EMDA/PRE-TUR) | completed | Phase 3 | 352 | University of Rome Tor VergataOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT01442519 | Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer(BCG/EMDA-MMC) | completed | Phase 3 | 212 | University of Rome Tor VergataOTHER | 1 | Sep 28, 2011 | clinicaltrials |
| NCT00236899 | Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC | completed | Phase 3 | 241 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT01441453 | Transient Elastography in Hepatectomy for Hepatocellular Carcinoma | unknown | N/A | 120 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT01253837 | L19TNFα in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT01437618 | First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer | completed | — | 15 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT01437826 | Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial | terminated | Phase 3 | 411 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT01387061 | Resection for Multiple Hepatocellular Carcinomas (HCC) | completed | N/A | 87 | University of MilanOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT01148628 | Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 54 | Southern Europe New Drug OrganizationOTHER | 2 | Sep 13, 2011 | clinicaltrials |
| NCT01155505 | Lenalidomide and Paclitaxel in Advanced Solid Tumors | unknown | Phase 1 | 28 | Southern Europe New Drug OrganizationOTHER | 2 | Sep 13, 2011 | clinicaltrials |
| NCT01221103 | Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL) | unknown | Phase 1 / Phase 2 | 50 | Southern Europe New Drug OrganizationOTHER | 1 | Sep 13, 2011 | clinicaltrials |
| NCT01430208 | A New Alternative to Traditional Hysteroscopy | completed | N/A | 401 | Catholic University of the Sacred HeartOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT00407459 | Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma | completed | Phase 2 | 77 | Armando Santoro, MDOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00302016 | Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 34 | Aug 26, 2011 | clinicaltrials |
| NCT00927511 | A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)(FIDeS) | unknown | Phase 2 | 104 | Regina Elena Cancer InstituteOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT01385891 | Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children(CLOVE) | completed | Phase 2 / Phase 3 | 40 | Istituto Giannina GasliniOTHER | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00910572 | Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | completed | Phase 2 | 60 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00940563 | A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors | completed | Phase 2 | 135 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00415194 | A Study for Patients With Head and Neck Cancer | completed | Phase 3 | 795 | Eli Lilly and CompanyINDUSTRY | 21 | Jun 28, 2011 | clinicaltrials |
| NCT00523419 | Chemotherapy for Patients With Osteosarcoma | completed | Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 5 | Jun 28, 2011 | clinicaltrials |
| NCT00568308 | Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma(PATHWAY) | terminated | Phase 3 | 600 | Progen PharmaceuticalsINDUSTRY | 10 | Jun 15, 2011 | clinicaltrials |
| NCT01116128 | Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients(D-MP) | terminated | Phase 2 | 8 | Fondazione EMN Italy OnlusOTHER | 1 | Jun 14, 2011 | clinicaltrials |
| NCT01233206 | Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles | completed | Phase 4 | 120 | University Magna GraeciaOTHER | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | completed | Phase 1 / Phase 2 | 48 | CTI BioPharmaINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT01368744 | Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology | completed | — | 150 | Sysmex America, Inc.INDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00851448 | Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients | terminated | N/A | 17 | Fresenius KabiINDUSTRY | 2 | Jun 2, 2011 | clinicaltrials |
| NCT01363739 | Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab(PROVETTA) | unknown | — | 265 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Jun 2, 2011 | clinicaltrials |
| NCT01115140 | Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women | completed | Phase 4 | 50 | University Magna GraeciaOTHER | 1 | May 24, 2011 | clinicaltrials |
| NCT00234468 | Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC | terminated | Phase 3 | 490 | AstraZenecaINDUSTRY | 1 | May 20, 2011 | clinicaltrials |
| NCT00325234 | Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer | completed | Phase 2 | 135 | Eli Lilly and CompanyINDUSTRY | 5 | May 20, 2011 | clinicaltrials |
| NCT00322517 | Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer | completed | Phase 2 | 90 | PfizerINDUSTRY | 5 | May 17, 2011 | clinicaltrials |
| NCT00616135 | Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy(RESTORE-2) | completed | Phase 4 | 71 | Cytori TherapeuticsINDUSTRY | 4 | May 17, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Apr 18, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00101595 | Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | completed | Phase 2 | 96 | Bristol-Myers SquibbINDUSTRY | 20 | Apr 14, 2011 | clinicaltrials |
| NCT00179621 | Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality | completed | Phase 3 | 205 | Celgene CorporationINDUSTRY | 9 | Apr 14, 2011 | clinicaltrials |
| NCT00400673 | A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia | completed | Phase 2 | 581 | Northern Italy Leukemia GroupOTHER | 1 | Apr 1, 2011 | clinicaltrials |
| NCT00372567 | Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors | terminated | Phase 3 | 69 | PfizerINDUSTRY | 7 | Mar 17, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials